Author’s Reply to Srinivas: “Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection”
Crossref DOI link: https://doi.org/10.1007/s40262-015-0336-5
Published Online: 2015-10-20
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Namour, Florence
License valid from 2015-10-20
